March 17, 2010 [Taoyuan, Taiwan]:

SHL General Manager, Frank Isaksson, will return to the 2010 Injectable Drug Delivery Conference. He will be discussing market trends in injectable drug delivery and the cooperation between device manufacturers & drug companies. This exclusive event will be held March 22nd -23rd at the Le Meridien Hotel in London, England.

SHL has been an active participant with injectable drug delivery related seminars. Frank has shared his extensive knowledge & experience at the Injectable Drug Delivery Conference and the Pre-filled Syringes & Injection Devices Conference over the past 5 years.

The GM has been with SHL for more than 15 years and is well experienced in all production aspects from concept to full-scaled manufacturing. He has an in-depth understanding of the industry, key pharmaceutical & biotechnology companies, suppliers, machines and regulatory affairs. He is dedicated in sharing his knowledge with others in the field.

Commenting on this important event, Frank stated, “This conference has provided us with a great venue for sharing knowledge and information. As a result we can gain a broader understanding of our patient and customer needs and provide more patient-friendly products to help with compliance and safety. It is an honor to be invited again and I look forward to speaking with everyone about our experience, especially related to auto-injectors and pen-injectors.”

About SHL

SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 1,500 staff globally (1000 staff in Taiwan), with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.

SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.

Our organization consists of three distinct group companies:

SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies

SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use

SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products

For additional information visit www.shl-group.com or contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it